Mango Lisa A's Form 4 filing
1Life Healthcare IncONEM · filed Nov 17, 2022
- Accession no.
- 0001562180-22-007754
- Filed
- Nov 17, 2022
- Trade date
- Nov 15-17, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $184.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mango Lisa ACIK 0001800511 | Officer (General Counsel and Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Common Stock | MOption exerciseAcquired | +2,472 | $12.16 | +$30,059.52 | 90,857 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −2,472 | $16.84F2 | −$41,628.48 | 88,385 | Direct | |
| Nov 15, 2022 | Common Stock | MOption exerciseAcquired | +8,542 | –F3 | – | 96,927 | Direct | |
| Nov 16, 2022 | Common Stock | SSaleDisposed | −4,230 | $16.82F5 | −$71,148.6 | 92,697 | Direct | |
| Nov 17, 2022 | Common Stock | SSaleDisposed | −4,312 | $16.71F6 | −$72,053.52 | 88,385 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Common Stock | MOption exerciseDisposed | −2,472 | $0.00 | $0 | 93,948 | Direct | |
| Nov 15, 2022 | Common Stock | MOption exerciseDisposed | −8,542 | $0.00 | $0 | 25,627 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $16.805 to $16.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Restricted stock units convert into the issuer's common stock on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $16.81 to $16.825. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $16.68 to $16.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.